Nurix Therapeutics NRIX
NASDAQ NRIX
$16.32 +0.44 (+2.77%)
As of: Nov 11, 2026 · 3:59 PM EST

Nurix Therapeutics (NRIX) Total Current Liabilities (2019 - 2026)

Updated

Nurix Therapeutics' Total Current Liabilities was $130.74 million in fiscal Q3 2026 (quarter ended Aug 31, 2026), up 58.8% from $82.35 million a year earlier and up 81.5% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Total Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025 (ended Nov 30, 2025), Total Current Liabilities at Nurix Therapeutics came in at $86.47 million, down 9.8% from FY2024.

  • Total Current Liabilities shows a five-year compound annual growth rate of 14.2% (FY2020 to FY2025).
  • In earlier fiscal years, Total Current Liabilities was $95.85 million in FY2024 (+10.2%), $86.96 million in FY2023 (+23.1%), $70.66 million in FY2022 (+6.6%) and $66.26 million in FY2021 (+48.8%).
  • The fiscal Q3 2026 figure marks the highest quarterly Total Current Liabilities in data going back to fiscal Q4 2019.
  • Compared with a year earlier, Total Current Liabilities was higher in four of the last eight quarters, with growth averaging 6.1%.
  • The best year-over-year quarter for Total Current Liabilities over five years was fiscal Q3 2026 (growth of 58.8%); the worst was fiscal Q4 2025 (a decline of 9.8%).
  • Per Business Quant data, NRIX's Total Current Liabilities in the three fiscal quarters before Q3 2026 was $72.02 million (Q2 2026), $92.2 million (Q1 2026) and $86.47 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 47.00 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 55.46 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 43.10 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 28.80 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -31.27 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 23.23 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 12.00 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 31.73 Bn
10 Nurix Therapeutics 1.73 Bn -891.35 Mn - 130.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 130.74 Mn
May 31, 2026 72.02 Mn
Feb 28, 2026 92.20 Mn
Nov 30, 2025 86.47 Mn
Aug 31, 2025 82.35 Mn
May 31, 2025 75.61 Mn
Feb 28, 2025 89.99 Mn
Nov 30, 2024 95.85 Mn
Aug 31, 2024 86.30 Mn
May 31, 2024 80.78 Mn
Feb 29, 2024 87.62 Mn
Nov 30, 2023 86.96 Mn
Aug 31, 2023 61.49 Mn
May 31, 2023 72.26 Mn
Feb 28, 2023 64.88 Mn
Nov 30, 2022 70.66 Mn
Aug 31, 2022 67.50 Mn
May 31, 2022 72.67 Mn
Feb 28, 2022 66.05 Mn
Nov 30, 2021 66.26 Mn
API Access

Nurix Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NRIX&period=max&api_key=YOUR_API_KEY